Deloitte Center for Health Solutions

Deloitte Insights

US health care can’t afford health inequities

Inequities in the US health system cost approximately $320 billion today and could eclipse $1 trillion in annual spending by 2040 if left unaddressed.

Deloitte Insights

The future of public health

Reimagining the programs, policies, and systems for strengthening public health

The future of the public’s health rests on prevention and wellness rather than treatment. What steps can public health leaders take to fulfill this vision?

Deloitte Insights

Enhancing clinical trial diversity

Stakeholder perspectives on advancing research through representative clinical trials

Racial and ethnic diversity among clinical trial participants is important to support science-driven strategies aimed at understanding the needs of those who are affected by the disease or condition being investigated. How can the biopharma industry achieve this? The answer lies in multistakeholder partnerships.

Analysis

Reinvigorating medtech innovation

Opportunities on the horizon

Venture capital investments in the medtech industry have declined. Find out how this may impact new innovations and life-saving treatments for patients.